|
US2490813A
(en)
|
1944-11-29 |
1949-12-13 |
Standard Oil Co |
Continuous process for making aryl amines
|
|
US3299078A
(en)
|
1962-10-01 |
1967-01-17 |
Smith Kline French Lab |
Pyrido [3', 4': 4, 5] pyrrolo [3, 2, 1-hi] indoles and-[3, 2, 1-ij] quinolines
|
|
US3813392A
(en)
|
1969-06-09 |
1974-05-28 |
J Sellstedt |
Pyrrolo(1,2,3-alpha epsilon)quinoxalin-2(3h)-ones and related compounds
|
|
US3914421A
(en)
|
1972-06-19 |
1975-10-21 |
Endo Lab |
Pyridopyrrolobenzheterocycles for combatting depression
|
|
US4115577A
(en)
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
US4238607A
(en)
|
1972-06-19 |
1980-12-09 |
Endo Laboratories Inc. |
Pyridopyrrolo benzheterocycles
|
|
US4183936A
(en)
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
|
IE41352B1
(en)
|
1974-04-01 |
1979-12-19 |
Pfizer |
5-aryl-1,2,3,4-tetrahydro- -carbolines
|
|
US4001263A
(en)
|
1974-04-01 |
1977-01-04 |
Pfizer Inc. |
5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
|
|
US4136145A
(en)
|
1974-07-05 |
1979-01-23 |
Schering Aktiengesellschaft |
Medicament carriers in the form of film having active substance incorporated therein
|
|
US4219550A
(en)
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4522944A
(en)
|
1982-12-23 |
1985-06-11 |
Erba Farmitalia |
Carboxamido-derivatives of 5H-1,3,4-thiadiazolo[3,2-a]pyrimidines, compositions and use
|
|
CH656884A5
(de)
|
1983-08-26 |
1986-07-31 |
Sandoz Ag |
Polyolester, deren herstellung und verwendung.
|
|
ATE59289T1
(de)
|
1985-10-09 |
1991-01-15 |
Desitin Arzneimittel Gmbh |
Verfahren zur herstellung einer darreichungsund dosierungsform fuer arzneimittel-wirkstoffe, reagentien oder andere wirkstoffe.
|
|
ES2058068T3
(es)
|
1986-03-19 |
1994-11-01 |
Kumiai Chemical Industry Co |
Derivados de 5h-1,3,4-tiadiazol-(3,2-a)-pirimidin-5-ona y compuestos fungicidas con contenido en dichos derivados.
|
|
EP0242690B1
(en)
|
1986-04-07 |
1993-06-30 |
Kumiai Chemical Industry Co., Ltd. |
5H-1,3,4-Thiadiazolo[3,2-a]pyrimidin-5-one derivatives and agricultural-horticultural fungicide composition containing the same
|
|
HU208484B
(en)
|
1988-08-17 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
|
|
US5114976A
(en)
|
1989-01-06 |
1992-05-19 |
Norden Michael J |
Method for treating certain psychiatric disorders and certain psychiatric symptoms
|
|
US5538739A
(en)
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
|
IT1271352B
(it)
|
1993-04-08 |
1997-05-27 |
Boehringer Ingelheim Italia |
Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
|
|
JP3016060B2
(ja)
|
1993-04-28 |
2000-03-06 |
本田技研工業株式会社 |
防振マウント装置
|
|
CN1074923C
(zh)
|
1993-11-19 |
2001-11-21 |
詹森药业有限公司 |
微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
|
|
JP4099224B2
(ja)
|
1994-03-02 |
2008-06-11 |
ナームローゼ・フエンノートチヤツプ・オルガノン |
舌下又はバッカル医薬組成物
|
|
CN1087725C
(zh)
|
1994-03-25 |
2002-07-17 |
同位素技术有限公司 |
用氘代方法增强药物效果
|
|
US5648542A
(en)
|
1996-02-29 |
1997-07-15 |
Xerox Corporation |
Arylamine processes
|
|
US5648539A
(en)
|
1996-02-29 |
1997-07-15 |
Xerox Corporation |
Low temperature arylamine processes
|
|
US5654482A
(en)
|
1996-02-29 |
1997-08-05 |
Xerox Corporation |
Triarylamine processes
|
|
DE19646392A1
(de)
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
|
|
US5705697A
(en)
|
1997-01-30 |
1998-01-06 |
Xerox Corporation |
Arylamine processes
|
|
US5723671A
(en)
|
1997-01-30 |
1998-03-03 |
Xerox Corporation |
Arylamine processes
|
|
US5723669A
(en)
|
1997-01-30 |
1998-03-03 |
Xerox Corporation |
Arylamine processes
|
|
TWI242011B
(en)
|
1997-03-31 |
2005-10-21 |
Eisai Co Ltd |
1,4-substituted cyclic amine derivatives
|
|
US6323366B1
(en)
|
1997-07-29 |
2001-11-27 |
Massachusetts Institute Of Technology |
Arylamine synthesis
|
|
GB2328686B
(en)
|
1997-08-25 |
2001-09-26 |
Sankio Chemical Co Ltd |
Method for producing arylamine
|
|
US6884429B2
(en)
|
1997-09-05 |
2005-04-26 |
Isotechnika International Inc. |
Medical devices incorporating deuterated rapamycin for controlled delivery thereof
|
|
US6395939B1
(en)
|
1997-10-06 |
2002-05-28 |
Massachusetts Institute Of Technology |
Diaryl ether condensation reactions
|
|
US5902901A
(en)
|
1998-05-07 |
1999-05-11 |
Xerox Corporation |
Arylamine processes
|
|
WO2000035419A2
(en)
|
1998-12-17 |
2000-06-22 |
Alza Corporation |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
|
NO309305B1
(no)
|
1999-02-19 |
2001-01-15 |
Norsk Hydro As |
Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater
|
|
PE20010052A1
(es)
|
1999-04-23 |
2001-01-27 |
Upjohn Co |
Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht
|
|
US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
MXPA01012969A
(es)
|
1999-06-15 |
2003-10-14 |
Bristol Myers Squibb Pharma Co |
Gamma-carbolinas fusionadas de heterociclo sustituido.
|
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
US6541639B2
(en)
|
2000-07-26 |
2003-04-01 |
Bristol-Myers Squibb Pharma Company |
Efficient ligand-mediated Ullmann coupling of anilines and azoles
|
|
PL366233A1
(en)
|
2000-12-20 |
2005-01-24 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
DE10123129A1
(de)
|
2001-05-02 |
2002-11-14 |
Berolina Drug Dev Ab Svedala |
Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel
|
|
US6849640B2
(en)
|
2001-08-08 |
2005-02-01 |
Pharmacia & Upjohn Company |
Therapeutic 1H-pyrido [4,3-b] indoles
|
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
EP1314554A1
(fr)
|
2001-11-23 |
2003-05-28 |
Kba-Giori S.A. |
Dispositif de décollage d'éléments de sécurité
|
|
DE10162121A1
(de)
|
2001-12-12 |
2003-06-18 |
Berolina Drug Dev Ab Svedala |
Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
|
|
KR100699516B1
(ko)
|
2002-07-29 |
2007-03-26 |
알자 코포레이션 |
팔리페리돈의 조절 전달을 위한 방법 및 복용 형태
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
US7223870B2
(en)
|
2002-11-01 |
2007-05-29 |
Pfizer Inc. |
Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction
|
|
AU2003287433A1
(en)
|
2002-11-01 |
2004-06-07 |
Oregon Health And Science University |
Treatment of hyperkinetic movement disorder with donepezil
|
|
PL377426A1
(pl)
|
2002-12-19 |
2006-02-06 |
Bristol-Myers Squibb Company |
Podstawione tricykliczne gamma-karboliny jako agoniści i antagoniści receptora serotoninowego
|
|
DK2009000T3
(da)
|
2003-01-16 |
2011-09-05 |
Acadia Pharm Inc |
Selektive serotonin 2A/2C-receptor invers-agonister som terapeutika for neurodegenerative sygdomme
|
|
AU2004259741A1
(en)
|
2003-07-21 |
2005-02-03 |
Smithkline Beecham Corporation |
(2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
|
|
AR045796A1
(es)
|
2003-09-26 |
2005-11-16 |
Solvay Pharm Bv |
Derivados de hexa y octahidro - pirido (1,2-a) pirazina con actividad antagonista de nk1. composiciones farmaceuticas.
|
|
JP2005259113A
(ja)
|
2004-02-12 |
2005-09-22 |
Ricoh Co Ltd |
プロセス編集装置、プロセス管理装置、プロセス編集プログラム、プロセス管理プログラム、記録媒体、プロセス編集方法及びプロセス管理方法
|
|
US20080280941A1
(en)
|
2004-03-05 |
2008-11-13 |
Pierre Lourtie |
8-Phenoxy-Gamma Carboline Derivatives
|
|
US20050222209A1
(en)
|
2004-04-01 |
2005-10-06 |
Zeldis Jerome B |
Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease
|
|
US7592454B2
(en)
|
2004-04-14 |
2009-09-22 |
Bristol-Myers Squibb Company |
Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
|
|
AU2005286943A1
(en)
|
2004-09-20 |
2006-03-30 |
Mount Sinai School Of Medicine |
Use of memantine (NAMENDA) to treat autism, compulsivity, and impulsivity
|
|
JP2008513432A
(ja)
|
2004-09-21 |
2008-05-01 |
ファイザー・プロダクツ・インク |
Ｃｎｓ状態の治療に有用なｎ−メチルヒドロキシエチルアミン
|
|
US7614727B2
(en)
|
2004-09-30 |
2009-11-10 |
Fujifilm Corporation |
Liquid ejection head, manufacturing method thereof, and image forming apparatus
|
|
WO2006063709A1
(en)
|
2004-12-15 |
2006-06-22 |
F.Hoffmann-La Roche Ag |
Bi- and tricyclic substituted phenyl methanones as glycine transporter i (glyt-1) inhibitors for the treatment of alzheimer’s disease
|
|
WO2006081332A1
(en)
|
2005-01-25 |
2006-08-03 |
Epix Delaware, Inc. |
Substituted arylamine compounds and their use as 5-ht6 modulators
|
|
JP2008528514A
(ja)
|
2005-01-25 |
2008-07-31 |
セルジーン・コーポレーション |
４−アミノ−２−（３−メチル−２，６−ジオキソピペリジン−３−イル）−イソインドール−１，３−ジオンを使用する方法及び組成物
|
|
CN101309917B
(zh)
|
2005-10-06 |
2013-09-11 |
奥斯拜客斯制药有限公司 |
具有增强治疗性质的胃h+，k+-atp酶氘代抑制剂
|
|
WO2007084841A2
(en)
|
2006-01-13 |
2007-07-26 |
Wyeth |
Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors
|
|
US7750168B2
(en)
|
2006-02-10 |
2010-07-06 |
Sigma-Aldrich Co. |
Stabilized deuteroborane-tetrahydrofuran complex
|
|
EP2068872A1
(en)
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
KR102065319B1
(ko)
|
2007-03-12 |
2020-01-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로환 융합 감마-카르볼린 합성
|
|
WO2009017836A1
(en)
|
2007-08-01 |
2009-02-05 |
Medivation Neurology, Inc. |
Methods and compositions for treating schizophrenia using antipsychotic combination therapy
|
|
WO2009023253A2
(en)
|
2007-08-15 |
2009-02-19 |
Arena Pharmaceuticals Inc. |
IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
|
|
US20090076159A1
(en)
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched eplivanserin
|
|
AU2009212065B2
(en)
|
2008-02-05 |
2014-03-20 |
Clera Inc. |
Compositions and methods for alleviating depression or improving cognition
|
|
MX2010008688A
(es)
|
2008-02-07 |
2010-08-30 |
Schering Corp |
Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria.
|
|
JP5611846B2
(ja)
|
2008-03-12 |
2014-10-22 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
置換ヘテロ環縮合ガンマ−カルボリン類固体
|
|
CN105168219B
(zh)
|
2008-05-27 |
2018-11-20 |
细胞内治疗公司 |
用于睡眠障碍和其他疾病的方法和组合物
|
|
US20100159033A1
(en)
|
2008-09-29 |
2010-06-24 |
Auspex Pharmaceuticals, Inc. |
Benzisoxazole modulators of d2 receptor, and/or 5-ht2a receptor
|
|
EP2560676B8
(en)
|
2010-04-22 |
2016-10-12 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
NZ612686A
(en)
|
2010-12-16 |
2015-11-27 |
Cynapsus Therapeutics Inc |
Sublingual films
|
|
WO2012088038A2
(en)
|
2010-12-21 |
2012-06-28 |
Albany Molecular Research, Inc. |
Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
|
|
WO2013155504A1
(en)
|
2012-04-14 |
2013-10-17 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
SG11201501894VA
(en)
|
2012-09-14 |
2015-04-29 |
Abbvie Inc |
Tricyclic quinoline and quinoxaline derivatives
|
|
HUE053159T2
(hu)
|
2013-03-15 |
2021-06-28 |
Intra Cellular Therapies Inc |
Szerves vegyületek
|
|
IL305990B2
(en)
|
2013-12-03 |
2025-12-01 |
Intra Cellular Therapies Inc |
Long-acting injectable composition comprising polymeric microspheres of heterocycle fused gamma-carboline compounds or a pharmaceutical composition for sustained or delayed release comprising the compounds and their use in the treatment of bipolar disorder i and/or bipolar ii disorder
|
|
RU2016143091A
(ru)
*
|
2014-04-04 |
2018-05-08 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
|
MX365969B
(es)
|
2014-04-04 |
2019-06-21 |
Intra Cellular Therapies Inc |
Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio.
|
|
WO2015191554A1
(en)
|
2014-06-09 |
2015-12-17 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of use to treat schizophrenia
|
|
JP6537601B2
(ja)
|
2015-05-12 |
2019-07-03 |
大鵬薬品工業株式会社 |
アザ二環式化合物の結晶
|
|
CA3254279A1
(en)
|
2015-06-03 |
2025-03-18 |
Triastek, Inc. |
PHARMACEUTICAL FORMS AND RELATED USES
|
|
WO2017117514A1
(en)
*
|
2015-12-31 |
2017-07-06 |
Tung Roger D |
Deuterated iti-007
|
|
CN108883111B
(zh)
|
2016-01-26 |
2021-10-08 |
细胞内治疗公司 |
有机化合物
|
|
PL3407889T3
(pl)
|
2016-03-25 |
2021-11-22 |
Intra-Cellular Therapies, Inc. |
Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego
|
|
US20200392135A1
(en)
|
2016-03-25 |
2020-12-17 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US11014925B2
(en)
|
2016-03-28 |
2021-05-25 |
Intra-Cellular Therapies, Inc. |
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
|
|
JP2019513143A
(ja)
|
2016-03-28 |
2019-05-23 |
イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． |
新規塩類および結晶
|
|
EP4001281A1
(en)
|
2016-08-09 |
2022-05-25 |
Teva Pharmaceuticals International GmbH |
Solid state forms of lumateperone ditosylate salt and preparation thereof
|
|
US11331316B2
(en)
|
2016-10-12 |
2022-05-17 |
Intra-Cellular Therapies, Inc. |
Amorphous solid dispersions
|
|
US10906906B2
(en)
|
2016-12-29 |
2021-02-02 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US10961245B2
(en)
|
2016-12-29 |
2021-03-30 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
|
IL268970B2
(en)
|
2017-03-24 |
2023-12-01 |
Intra Cellular Therapies Inc |
Oral transmucosal formulations of substituted heterocycle fused gamma carbolines
|
|
JP7224333B2
(ja)
|
2017-07-26 |
2023-02-17 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
JP7223742B2
(ja)
|
2017-07-26 |
2023-02-16 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
US11655251B2
(en)
*
|
2017-11-27 |
2023-05-23 |
Egis Gyogyszergyar Zrt. |
Method for the production of lumateperone and its salts
|
|
WO2019178484A1
(en)
|
2018-03-16 |
2019-09-19 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
WO2019183546A1
(en)
|
2018-03-23 |
2019-09-26 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
AU2019240226B2
(en)
|
2018-03-23 |
2024-11-28 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
IL321985A
(en)
|
2018-06-06 |
2025-09-01 |
Intra Cellular Therapies Inc |
New salts and crystals
|
|
WO2019237037A1
(en)
|
2018-06-08 |
2019-12-12 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
|
EP3843729A4
(en)
|
2018-08-29 |
2022-06-01 |
Intra-Cellular Therapies, Inc. |
NOVEL COMPOSITIONS AND PROCESSES
|
|
EP4034119A4
(en)
|
2019-09-25 |
2023-10-18 |
Intra-Cellular Therapies, Inc. |
NOVEL METHODS
|
|
JP2025521115A
(ja)
|
2022-05-18 |
2025-07-08 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
新規方法
|